Stock listing

Impact Therapeutics, Inc. Class H

Selected listing: 7630 · HKEX · HKD · HK

Impact Therapeutics, Inc. Class H (HKEX:7630), Health Technology. Latest release Jul 31, 2026: IMPACT Therapeutics Signs Exclusive License Agreement…

7630:HKEXHKDHKUpdated October 3, 2026
Ticker
HKEX:7630
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

About Impact Therapeutics, Inc. Class H

Impact Therapeutics, Inc. Class H is a publicly traded company on the Hong Kong market under the ticker 7630. Focused on the biotechnology sector, Impact Therapeutics is dedicated to advancing innovative therapies.

Latest news from Impact Therapeutics, Inc. Class H

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

July 31, 2026

ARTICLES OF ASSOCIATION

June 25, 2026

Next Day Disclosure Return

June 10, 2026

All Impact Therapeutics, Inc. Class H news →

Research Impact Therapeutics, Inc. Class H

Impact Therapeutics, Inc. Class H company profile

View the public company page for Impact Therapeutics, Inc. Class H on 6ix.

Impact Therapeutics, Inc. Class H news

Read company news and market updates connected to Impact Therapeutics, Inc. Class H.

Impact Therapeutics, Inc. Class H investor events

Find investor webinars, events, and replay context for Impact Therapeutics, Inc. Class H.